Stock listing
Euronext:SEQUA Sequana Medical N.V Aandeel
Home listing (Euronext) of Sequana Medical N.V
Follow Sequana Medical N.V into a list and get an email when it puts out news.
Share price · EURONEXT:SEQUA
€0.611 EUR 0.000 (0.0%)
Close on Nov 20, 2026
- Day range
- €0.560 – €0.669 EURNov 20, 2026
- Market cap
- €47.76M EURAt the close on Nov 20, 2026 · price × 78.17M shares outstanding
- 52-week range
- €0.460 – €0.865 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €0 EURMedian day 0 shares · 66 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:SEQUA · Home | €0.611 EUR | 0.000 (0.0%) | — | €0.669 | €0.669 | €0.560 | €0.611 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · EURONEXT:SEQUA · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.669 | €0.669 | €0.560 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 | |
| €0.611 | 0.000 | 0.0% | €0.611 | €0.611 | €0.611 | 0 |
- Ticker
- Euronext:SEQUA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Euronext
- Currency
- EUR
What changed lately
Latest news release · Jun 29, 2026
Sequana Medical NV - Board decision to file for bankruptcy
Latest deck · January 2026
Investor Presentation (January 2026)
Investor deck · 24 slides
Latest news
Sequana Medical NV - Board decision to file for bankruptcy
Jun 29, 2026
Closed €0.611 (0.0%) on Jun 29, 2026
Board decision to file for bankruptcy
Jun 26, 2026
Closed €0.611 (0.0%) on Jun 29, 2026
Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026
May 29, 2026
Closed €0.611 (0.0%) on May 29, 2026
Sequana Medical announces results of Annual General Meeting of Shareholders
May 28, 2026
Closed €0.611 (0.0%) on May 29, 2026
Financial and Strategic Review, Annual General Meeting, and Trading Halt
Apr 28, 2026
Closed €0.611 (0.0%) on Apr 29, 2026
New share capital amount and new number of shares / issuance of a new subscription request notice under the share subscription facility agreement with GEM
Mar 26, 2026
Closed €0.487 (-3.1%) on Mar 27, 2026
Sequana Medical Reports Strong US Commercial Progress with Five Centers Completing alfapump® System Implants Since Launch
Feb 26, 2026
Closed €0.609 (+4.6%) on Feb 26, 2026
Sequana Medical announces the issuance of a subscription request notice under the share subscription facility agreement with GEM
Feb 2, 2026
Closed €0.595 (-9.7%) on Feb 3, 2026
Sequana Medical announces new share capital amount and new number of shares
Jan 27, 2026
Closed €0.605 (-3.0%) on Jan 27, 2026
Transparency Notification from Shareholders
Jan 6, 2026
Closed €0.554 (+4.5%) on Jan 7, 2026
Sequana Medical N.V on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 16 in the last 12 months · 25 in all · newest Jun 29, 2026 · oldest 2025
- Decks
- 81 decks · latest January 2026
Where Sequana Medical N.V is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:SEQUA · Home listing · This page | Euronext | Belgium | EUR |
| Frankfurt:2SE | Frankfurt | Germany | EUR |
| gettex:2SE | gettex | Germany | EUR |
| OTC:SQNMF | OTC | United States | USD |
| LS Exchange:A2PD78 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PD78 | Lang & Schwarz | Germany | EUR |
| Aquis:SEQUAB | Aquis | United Kingdom | EUR |
| Aquis:SEQUAB | Aquis | United Kingdom | EUR |
| Stuttgart:2SE | Stuttgart | Germany | EUR |
| Dusseldorf:2SE | Dusseldorf | Germany | EUR |
| Munich:2SE | Munich | Germany | EUR |
Valuation
balance Jun 30, 2025 · price Nov 20, 2026
- Enterprise value
- €81.85M EUR
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Sequana Medical N.V · EURONEXT:SEQUA | US$52.42M | US$89.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| P&S Robotics Co., Ltd. · KRX:460940 | US$54.38M | US$33.62M | 26.6× | 5.9× | 36.6× | 1.7× | 36.0% | 0.0× | n/a |
| Creo Medical Group PLC · LSE:CREO | US$54.06M | US$49.48M | 7.8× | 6.3× | n/a | 0.9× | 88.3% | 0.1× | n/a |
| Crystalvue Medical Co Ltd · TPEX:6527 | US$53.82M | US$52.19M | 12.1× | 1.8× | 8.7× | 1.7× | 15.5% | 0.0× | n/a |
| 3D Global Biotech Inc. · TPEX:6808 | US$53.26M | US$38.17M | 26.4× | 6.1× | 17.5× | 2.4× | 32.2% | 0.0× | n/a |
| Outset Medical, Inc. · NASDAQ:OM | US$53.03M | US$14.77M | n/a | 0.1× | n/a | 0.6× | −58.3% | 1.2× | 1.74 |
| NeurAxis, Inc. · AMEX:NRXS | US$52.99M | US$48.80M | n/a | 7.5× | n/a | 14.6× | −185.2% | 0.1× | 1.77 |
| Positron Corp. · OTC:POSC | US$52.29M | US$50.70M | n/a | 116× | n/a | n/a | n/a | n/a | 0.36 |
| BenQ Medical Technology Corp. · TPEX:4116 | US$52.13M | US$39.99M | 22.0× | 0.3× | 2.1× | 1.6× | 1.5% | 0.6× | n/a |
| Envoy Medical, Inc. · NASDAQ:COCH | US$51.89M | US$38.10M | n/a | 165× | n/a | n/a | n/a | n/a | 1.04 |
| OSTEONIC Co., Ltd. · KRX:226400 | US$50.52M | US$37.57M | 6.7× | 1.0× | 3.8× | 0.9× | 20.0% | 0.1× | n/a |
| Median of the others | US$53.01M | US$39.08M | 17.0× | 6.0× | 8.7× | 1.6× | 17.8% | 0.1× | 1.39 |
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 1.50 EUR · Analysts' mean
- EPS, year to Dec 2025
- -0.41 · 2 analysts
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Dec 31, 2025 | Mar 25, 2026 | −1.2% |
| Quarter to Sep 30, 2025 | Dec 3, 2025 | −4.1% |
| Q2 2025 | Sep 25, 2025 | −12.9% |
| Quarter to Mar 31, 2025 | Apr 22, 2025 | +3.2% |
| Q4 2024 | Mar 18, 2025 | −19.5% |
| Q3 2024 | Nov 27, 2024 | −5.1% |
| Q2 2024 | Sep 30, 2024 | −34.7% |
| Q1 2024 | May 23, 2024 · Before open | +4.7% |
| Q4 2023 | Mar 28, 2024 | −2.6% |
| Q3 2023 | Nov 29, 2023 | +7.7% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2023 | Sep 14, 2023 | +7.4% |
| Q1 2023 | May 31, 2023 | −0.3% |
| Q4 2022 | Feb 8, 2023 · After close | −5.8% |
| Q3 2022 | Nov 30, 2022 | −2.4% |
| Q2 2022 | Sep 8, 2022 | +3.3% |
| Q1 2022 | Apr 26, 2022 · After close | −2.9% |
| Q3 2021 | Dec 1, 2021 | −0.6% |
| Q2 2021 | Sep 2, 2021 · Before open | −5.2% |
| Q4 2020 | Mar 17, 2021 · Before open | −0.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2026) | Investor deck | 24 slides | January 2026 |
| Investor Presentation (November 2025) | Investor deck | 25 slides | November 2025 |
| Investor Presentation (September 2025) | Investor deck | 25 slides | September 2025 |
| Investor Presentation (June 2025) | Investor deck | 24 slides | June 2025 |
| Corporate Update (January 2025) | Corporate update | 47 slides | Jan 8, 2025 |
| Investor Presentation (January 2025) | Investor deck | 27 slides | January 2025 |
| Investor Presentation (May 2024) | Investor deck | 25 slides | May 2024 |
| VFB Happening 2024 | Conference | 19 slides | Mar 23, 2024 |
| Investor Presentation (December 2023) | Investor deck | 67 slides | December 2023 |
| Investor Presentation (December 2023) | Investor deck | 68 slides | December 2023 |
Show 50 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Finance Avenue 2023 | Conference | 23 slides | Nov 18, 2023 |
| VFB Biotech XL 2023 | Conference | 25 slides | Nov 14, 2023 |
| Investor Presentation (October 2023) | Investor deck | 30 slides | Oct 24, 2023 |
| Corporate Update (October 2023) | Corporate update | 33 slides | Oct 19, 2023 |
| Investor Presentation (October 2023) | Investor deck | 68 slides | October 2023 |
| H1 2023 Earnings Presentation | Earnings | 15 slides | Sep 14, 2023 |
| Investor Presentation (September 2023) | Investor deck | 56 slides | September 2023 |
| Investor Presentation (June 2023) | Investor deck | 36 slides | Jun 28, 2023 |
| EASL Congress 2023 | Conference | 23 slides | Jun 21, 2023 |
| Investor Presentation (June 2023) | Investor deck | 32 slides | Jun 16, 2023 |
| Investor Presentation (June 2023) | Investor deck | 55 slides | June 2023 |
| VFB Happening 2023 | Conference | 28 slides | Mar 25, 2023 |
| BioCapital Europe 2023 | Conference | 21 slides | Mar 3, 2023 |
| Investor Presentation (March 2023) | Investor deck | 38 slides | Mar 2, 2023 |
| Investor Presentation (March 2023) | Investor deck | 31 slides | March 2023 |
| FY2022 Earnings Presentation | Earnings | 18 slides | Feb 9, 2023 |
| Investor Presentation (February 2023) | Investor deck | 52 slides | February 2023 |
| Investor Presentation (January 2023) | Investor deck | 50 slides | January 2023 |
| Investor Presentation (December 2022) | Investor deck | 27 slides | December 2022 |
| Investor Presentation (November 2022) | Investor deck | 34 slides | Nov 17, 2022 |
| Jefferies London Healthcare Conference 2022 | Conference | 21 slides | Nov 17, 2022 |
| Investor Presentation (November 2022) | Investor deck | 48 slides | November 2022 |
| Corporate Update (October 2022) | Corporate update | 18 slides | Oct 25, 2022 |
| Investor Presentation (October 2022) | Investor deck | 33 slides | Oct 11, 2022 |
| H1 2022 Earnings Presentation | Earnings | 14 slides | Sep 8, 2022 |
| Investor Presentation (September 2022) | Investor deck | 46 slides | September 2022 |
| Corporate Update (July 2022) | Corporate update | 20 slides | Jul 19, 2022 |
| H.C. Wainwright Global Investment Conference (May 2022) | Conference | 27 slides | May 18, 2022 |
| Needham Healthcare Conference, April 2022 | Conference | 27 slides | Apr 13, 2022 |
| FY2021 Earnings Presentation | Earnings | 17 slides | Apr 12, 2022 |
| Investor Presentation (April 2022) | Investor deck | 49 slides | April 2022 |
| Investor Presentation (April 2022) | Investor deck | 47 slides | April 2022 |
| Oppenheimer Healthcare Conference 2022 | Conference | 27 slides | Mar 17, 2022 |
| H.C. Wainwright BioConnect Virtual Conference 2022 | Conference | 25 slides | Jan 10, 2022 |
| Investor Presentation (January 2022) | Investor deck | 50 slides | January 2022 |
| Corporate Update (December 2021) | Corporate update | 17 slides | Dec 7, 2021 |
| Finance Avenue 2021 | Conference | 27 slides | Nov 20, 2021 |
| Jefferies London Healthcare Conference 2021 | Conference | 28 slides | Nov 16, 2021 |
| Bolero Biotech event 2021 | Conference | 31 slides | Oct 28, 2021 |
| VFB Happening 2021 | Conference | 20 slides | Oct 23, 2021 |
This page holds 50 of 81 decks. Open Decks
Financings
| Raise | Date |
|---|---|
| New shares Announced: raise Buyers: GEM (to subscribe for between 50% and 150% of the Draw Down Amount of up to 2,999,900 new shares) | Feb 2, 2026 |
| New shares Closed: €0.5665 a share Buyers: GEM Global Yield LLC SCS (1,243,695 new shares at EUR 0.5665 per share) | Jan 27, 2026 |
| New shares Closed: €0.7907 a share Buyers: GEM (between a minimum of 50% and a maximum of 150% of the Draw Down Amount of up to 2,500,000 new shares); GEM Global Yield LLC SCS (2,614,848 new shares) | Oct 16, 2025 |
| New shares Announced: raise Buyers: GEM (between 50% and 150% of the Draw Down Amount of up to 2,750,000 shares) | Oct 16, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in EUR
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 106.0K | 712.2K | 922.7K | 370.5K | 963.3K | 970.6K | 1.03M | 1.30M | 1.49M | 1.68M |
| Cost of revenue | 26.4K | 164.1K | 204.6K | 76.7K | 202.4K | 197.8K | 158.1K | 212.4K | 320.4K | 359.2K |
| Gross profit | -2.22M | 548.0K | 718.1K | 293.8K | 760.9K | 772.9K | 871.1K | 1.09M | 1.17M | 1.33M |
| Research and development | 1.68M | 5.28M | 7.71M | 6.14M | 1.86M | 2.52M | 934.8K | 1.17M | 1.15M | 995.0K |
| Selling, general and administrative | 6.31M | 6.94M | 6.69M | 5.10M | 4.42M | 4.26M | 5.76M | 1.99M | 4.06M | 3.29M |
| Operating income | -18.7M | -28.9M | -28.1M | -22.6M | -17.8M | -14.1M | -13.0M | -7.57M | -13.7M | -11.4M |
| Depreciation and amortization | 615.0K | 661.3K | 311.5K | 408.5K | 306.5K | 244.1K | 22.0K | 77.9K | 80.1K | 46.5K |
| EBITDA | -18.1M | -28.2M | -27.8M | -22.2M | -17.5M | -13.8M | -13.0M | -7.49M | -13.7M | -11.4M |
| Interest expense | 26.4M | 4.29M | 2.73M | 854.5K | 1.35M | 770.6K | 922.0K | 635.5K | 190.1K | 88.5K |
| Income before tax | -44.4M | -32.1M | -30.4M | -23.2M | -18.9M | -14.8M | -14.0M | -8.21M | -13.9M | -11.5M |
| Income tax | 280.0K | 465.6K | 386.6K | 393.3K | 157.0K | 136.0K | 23.6K | 18.4K | 40.6K | 44.5K |
| Net income | -44.7M | -32.6M | -30.8M | -23.6M | -19.1M | -15.0M | -14.0M | -8.23M | -14.0M | -11.6M |
| Earnings per share, basic | -1.22 | -1.22 | -1.35 | -1.30 | -1.25 | -1.22 | -1.02 | -0.60 | -1.02 | -0.85 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 3.81M | 2.58M | 18.9M | 9.60M | 11.0M | 5.59M | 1.32M | 1.68M | 797.5K | 1.43M |
| Receivables | 301.2K | 43.1K | 113.9K | 81.9K | 23.6K | 624.7K | 430.0K | 303.5K | 571.0K | 258.3K |
| Inventory | 2.05M | 2.30M | 2.62M | 2.14M | 1.47M | 1.60M | 1.24M | 1.27M | 1.96M | 2.14M |
| Current assets | 6.42M | 6.30M | 23.1M | 12.9M | 13.4M | 8.52M | 3.10M | 3.27M | 3.40M | 4.42M |
| Property, plant and equipment | 2.32M | 2.07M | 1.27M | 704.7K | 606.7K | 45.5K | 20.1K | 30.9K | 160.1K | |
| Total assets | 9.94M | 10.1M | 26.0M | 14.7M | 14.2M | 9.35M | 3.34M | 3.52M | 3.81M | 4.68M |
| Accounts payable | 1.89M | 2.74M | 3.23M | 2.19M | 2.01M | 1.69M | 1.91M | 908.9K | 1.80M | 1.30M |
| Current liabilities | 53.2M | 19.5M | 15.1M | 7.18M | 5.97M | 5.31M | 18.7M | 5.55M | 4.84M | 4.12M |
| Long-term debt | 0 | 8.97M | 12.2M | 7.32M | 7.47M | 2.26M | 2.58M | 1.76M | 4.66M | |
| Total debt | 40.1M | 16.8M | 16.7M | 7.32M | 7.47M | 3.22M | 14.7M | 4.58M | 4.66M | |
| Total liabilities | 54.3M | 29.6M | 28.2M | 15.5M | 14.1M | 8.42M | 22.1M | 8.13M | 10.5M | 4.97M |
| Shareholders' equity | -44.4M | -19.5M | -2.15M | -786.9K | 112.8K | 925.9K | -18.8M | -4.61M | -6.67M | -284.7K |
| Shares outstanding | 36.6M | 26.8M | 22.8M | 18.2M | 15.3M | 12.3M | 13.7M | 13.7M | 13.7M | 13.7M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -20.3M | -29.1M | -27.5M | -23.6M | -17.0M | -18.5M | -9.88M | -8.69M | -12.7M | -11.3M |
| Capital spending | -95.0K | -710.8K | -676.7K | -325.8K | -138.0K | -333.0K | -38.6K | -6.52K | -214.7K | -88.8K |
| Free cash flow | -20.5M | -29.8M | -28.2M | -23.9M | -17.1M | -18.8M | -9.91M | -8.70M | -13.0M | -11.3M |
| Cash from investing | -100.0K | -721.4K | -653.1K | -338.2K | -142.0K | -337.0K | -54.9K | -10.3K | -217.0K | -108.1K |
| Cash from financing | 21.6M | 13.5M | 37.3M | 22.4M | 22.6M | 23.2M | 9.47M | 9.81M | 12.2M | 8.22M |
| Share buybacks | 26.2M | 1.59K | 9.81M | 7.88M | 8.24M | |||||
| Change in cash | 1.22M | -16.3M | 9.19M | -1.52M | 5.48M | 4.27M | -366.1K | 886.4K | -629.5K | -2.66M |
Cap table
Built by 6ix from Sequana Medical N.V’s releases · as of Feb 2, 2026
- Common shares
- 78,172,033
- Fully diluted
- 78,172,033
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 78,172,033 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 78,172,033 |
Log in to ask 6ix AI your own questions about Sequana Medical N.V.